{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:35:31Z","timestamp":1789706131241,"version":"4.0.1"},"reference-count":16,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IRDR"],"published-print":{"date-parts":[[2024,8,31]]},"DOI":"10.5582\/irdr.2024.01035","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T22:11:37Z","timestamp":1724105497000},"page":"185-189","source":"Crossref","is-referenced-by-count":4,"title":["Skeletal computed tomography findings of upper extremities in middle-aged persons with thalidomide embryopathy"],"prefix":"10.5582","volume":"13","author":[{"given":"Chihiro","family":"Kamimura","sequence":"first","affiliation":[{"name":"Department of Rehabilitation Medicine, National Center for Global Health and Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Fujitani","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, National Center for Global Health and Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Aizawa","sequence":"additional","affiliation":[{"name":"Department of Radiological Physics and Technology, National Center for Global Health and Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Saotome","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, National Center for Global Health and Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, The University of Tokyo Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Haga","sequence":"additional","affiliation":[{"name":"National Rehabilitation Center for Persons with Disabilities, Saitama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Newbronner E, Atkin K. The changing health of Thalidomide survivors as they age: A scoping review. Disabil Health J. 2018; 11:184-191.","DOI":"10.1016\/j.dhjo.2017.09.004"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Merkle TP, Beckmann N, Bruckner T, Zeifang F. Shoulder joint replacement can improve quality of life and outcome in patients with dysmelia: A case series. BMC Musculoskelet Disord. 2016; 17:185.","DOI":"10.1186\/s12891-016-1031-x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Newman RJ. Shoulder joint replacement for osteoarthrosis in association with thalidomide-induced phocomelia. Clin Rehabil. 1999; 13:250-252.","DOI":"10.1191\/026921599675691977"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ghassemi Jahani SA, Danielson B, Karlsson J, Danielsson AJ. Long-term follow-up of thalidomide embryopathy: malformations and development of osteoarthritis in the lower extremities and evaluation of upper extremity function. J Child Orthop. 2014; 8:423-33.","DOI":"10.1007\/s11832-014-0609-9"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kimmeyer M, Lehmann LJ, Gerhardt C, Schmalzl J. Development and function of a natural reverse shoulder in a patient with thalidomide-induced dysmelia. JSES Rev Rep Tech. 2021; 1:60-64.","DOI":"10.1016\/j.xrrt.2020.11.009"},{"key":"#cr-split#-6.1","unstructured":"6. Kayamori R. Diagnostic Procedure for Thalidomide Embryopathy (TE). In: Guide for the Management of Thalidomide Embryopathy (Hinoshita F, eds.). The Research Group on grasping the health and living situation as well as creating the support infrastructure for thalidomide-impaired people in Japan, Japan, 2020"},{"key":"#cr-split#-6.2","unstructured":"pp. 22-29. <i>https:\/\/thalidomide-embryopathy.com\/common\/data\/pdf\/guide_2020_en.pdf <\/i>(accessed May 23, 2024)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kayamori R. Post-thalidomide syndrome 50 Years. Jpn J Rehabil Med. 2013; 50:957-996 (In Japanese).","DOI":"10.2490\/jjrmc.50.957"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bent N, Tennant A, Neumann V, Chamberlain MA. Living with thalidomide: Health status and quality of life at 40 years. Prosthet Orthot Int. 2007; 31:147-156.","DOI":"10.1080\/03093640600988567"},{"key":"9","unstructured":"9. Thalidomide Victims Association of Canada. Study on the current living conditions of Canadian thalidomide survivors and projections for the future. <i>https:\/\/thalidomide.ca\/wp-content\/uploads\/2017\/12\/2013-study-report.pdf<\/i> (accessed May 23, 2024)."},{"key":"10","unstructured":"10. Kreipe U. Abnormalities of internal organs in thalidomide embryopathy. A contribution to the determination of the sensitivity phase in thalidomide administration during early pregnancy. Arch Kinderheilkd. 1967; 176:33-61."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lenz W, Knapp K. Thalidomide embryopathy. Archives of environmental health. 1962; 5:2:14-19.","DOI":"10.1080\/00039896.1962.10663250"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nowack E. The sensitive phase in thalidomide embryopathy. Humangenetik. 1965; 1:516-536.","DOI":"10.1007\/BF00338341"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Henkel L, Willert H. Dysmelia. A classification and a pattern of malformation in a group of congenital defects of the limbs. J Bone Joint Surg Br. 1969; 51:399-414.","DOI":"10.1302\/0301-620X.51B3.399"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Mansour S, Baple E, Hall CM. A clinical review and introduction of the diagnostic algorithm for thalidomide embryopathy (DATE). J Hand Surg Eur. 2019; 44:96-108.","DOI":"10.1177\/1753193418800631"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Smithells RW, Newman GH. Recognition of thalidomide defects. J Med Genet. 1992; 29:716-723.","DOI":"10.1136\/jmg.29.10.716"}],"container-title":["Intractable &amp; Rare Diseases Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/13\/3\/13_2024.01035\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T05:05:39Z","timestamp":1725685539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/13\/3\/13_2024.01035\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,31]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5582\/irdr.2024.01035","relation":{},"ISSN":["2186-361X","2186-3644"],"issn-type":[{"value":"2186-361X","type":"electronic"},{"value":"2186-3644","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,31]]},"article-number":"2024.01035"}}